1-3 of 3
Teresita Lopez, BS
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Complete Tumor Responses in Lymphoma Patients Who Receive Autologous Cytotoxic T Lymphocytes Targeting EBV Latent Membrane Proteins

Catherine M. Bollard, MD, Maja Stanojevic, BS, Ann M. Leen, PhD, Teresita Lopez, BS, Andrea N. Sheehan, MD, George Carrum, MD, Hao Liu, PhD, Chung-Che Chang, MD, Adrian P. Gee, PhD, Malcolm K. Brenner, MD, PhD, Cliona M. Rooney, PhD, Helen E. Heslop, MD, Stephen Gottschalk, MD
Journal: Blood
Blood (2008) 112 (11): 230.
https://doi.org/10.1182/blood.V112.11.230.230
Published: 2008
Journal Articles

The Use of Autologous LMP2-Specific Cytotoxic T Lymphocytes (CTL) for the Treatment of Relapsed EBV-Positive Hodgkin Disease and Non-Hodgkin Lymphoma.

Catherine M. Bollard, MD, Elizabeth Buza, BS, Helen Huls, BS, Teresita Lopez, BS, Stephen Gottschalk, MD, George Carrum, MD, Vicky Gresik, MD, Jeff Chang, MD, Adrian P. Gee, PhD, Malcolm K. Brenner, MD, PhD, Cliona M. Rooney, PhD, Helen E. Heslop, MD
Journal: Blood
Blood (2005) 106 (11): 773.
https://doi.org/10.1182/blood.V106.11.773.773
Published: 2005
Journal Articles

LMP2-Cytotoxic T Lymphocyte Therapy for Relapsed EBV Positive Lymphoma.

Catherine M. Bollard, MD, Helen M. Huls, BS, Karin C. Straathof, MD, Stephen M. Gottschalk, MD, Teresita Lopez, BS, Chung-Che Chang, MD, PhD, Mary V. Gresik, MD, George Carrum, MD, Malcolm K. Brenner, MD, PhD, Cliona M. Rooney, PhD, Helen E. Heslop, MD
Journal: Blood
Blood (2004) 104 (11): 3276.
https://doi.org/10.1182/blood.V104.11.3276.3276
Published: 2004